Shares of Alexandria Real Estate Equities Inc. slipped 3.17% to $71.86 Monday, on what proved to be an all-around grim ...

We came across a bullish thesis on Alexandria Real Estate Equities, Inc. on Compounding Dividends’s Substack by TJ ...

ARE offers a 6.4% dividend yield at a steep discount, with strong long-term fundamentals and a leading position in life sciences real estate. Read the full REIT analysis here.

The stock's rise snapped a three-day losing streak.

Alexandria Real Estate Equities has approximately 1,000 clients and 74.6 million square feet of space. Its tenants include major pharmaceutical, biotech, and life sciences companies; government ...

Alexandria Real Estate (NYSE:ARE) is set to give its latest quarterly earnings report on Monday, 2025-07-21. Here's what investors need to know before the announcement. Analysts estimate that ...

Alexandria Real Estate is still good value based on its forward 5y P/AFFO/GY ratio of 1.61 and thus justifies a moderate buy rating. Long $ ARE Alexandria is a substantially healthy tree.

Q2 2025 Earnings Call Transcript July 22, 2025 Operator: Good day, and welcome to the Alexandria Real Estate Equities Second Quarter 2025 Conference Call. [Operator Instructions] Please note, today’s ...

Review the current Alexandria Real Estate Equities Inc (ARE:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if ARE is the best investment for you.

Shares of Alexandria Real Estate Equities Inc. ARE slipped 1.82% to $78.03 Wednesday, on what proved to be an all-around grim ...

Alexandria has another $178 million in non-core real estate sales set to close and $874 million in targeted sales in the second half of this year. The pending sales total $1.052 billion.